However, the risk score model was discussed as a whole in these two studies, and the potential role of HSPA4, as a single factor, on the diagnosis, prognosis, DNA methylation, immune cell infiltration, and immune checkpoint of HCC has not been described. The gene discussed is HSPA4; the disease is hepatocellular carcinoma.